DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Griseofulvin is a drug marketed by Actavis Mid Atlantic, Chartwell Rx, Cipla, Cosette, Sandoz Inc, Sigmapharm Labs Llc, and Mountain. and is included in nine NDAs.
The generic ingredient in GRISEOFULVIN is griseofulvin, ultramicrosize. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the griseofulvin, ultramicrosize profile page.
A generic version of GRISEOFULVIN was approved as griseofulvin, ultramicrosize by MOUNTAIN on January 9th, 2014.
Recent Clinical Trials for GRISEOFULVIN
Identify potential brand extensions & 505(b)(2) entrants
|Henry Ford Health System||N/A|
|Laboratorios Grossman, S.A.||Phase 3|